You are viewing the site in preview mode

Skip to main content

Table 1 Basic data and laboratory parameters of control and stone patients

From: Post-ESWL urinary osteopontin level and ion-activity product of calcium oxalate are associated with stone recurrence after 5-year follow-up

 

Control (n = 13)

Stone patients

Before ESWL (n = 54)

2 wk after ESWL (n = 44)

4 wk after ESWL (n = 37)

Age (years)

54.5 ± 3.8

53.8 ± 3.0

  

BMI ((kg/m2)

23.6 ± 0.4

23.5 ± 0.7

  

Stone size (mm)

0

9.1 ± 2.3*

  

Urine pH

6.0 ± 0.1

6.2 ± 0.2

6.0 ± 0.2

6.1 ± 0.1

eGFR (ml/min/1.73 m²)

88.3 ± 4.7

87.6 ± 5.4

88.2 ± 5.6

85.1 ± 4.6

APCaOx

2.4 ± 0.9

4.7 ± 1.1*

4.8 ± 1.1#

4.7 ± 1.1+

Oxalate (mg/24 h)

9.1 ± 1.8

40.4 ± 4.9*

47.8 ± 7.5#

44.6 ± 11.9+

Citric acid (mg/24 h)

365.8 ± 42.1

102.4 ± 20.4*

96.8 ± 13.1#

86.9 ± 16.9+

Urine protein (g/24 h)

0.09 ± 0.01

0.07 ± 0.02

0.07 ± 0.02

0.08 ± 0.01

αGST (µg/g Cr)

5.3 ± 0.8

28.4 ± 5.9*

26.3 ± 3.6#

25.7 ± 3.3+

πGST (µg /g Cr)

4.9 ± 0.6

22.8 ± 4.5*

19.1 ± 4.1#

20.7 ± 3.8+

MDA (µmol/g Cr)

11.7 ± 2.4

44.5 ± 2.3*

41.8 ± 2.2#

39.8 ± 2.4+

  1. * p < 0.05 when compared with the controls;
  2. # p < 0.05 when compared with stone patients before ESWL;
  3. + p < 0.05 when compared with stone patients 2 weeks after ESWL
  4. Abbreviations: BMI, body mass index; ESWL, extracorporeal shock wave lithotripsy; APCaOx, ion-activity product of calcium oxalate; αGST, alpha-glutathione S-transferase; πGST, pi-glutathione S-transferase; MDA, malondialdehyde; Cr, creatinine